Linda Liau, MD, MBA

Linda Liau, MD, PhD, MBA

Professor and Chair, Department of Neurosurgery
Director, Brain Tumor Program, Department of Neurosurgery
Member, Brain Research Institute




Neurological Surgery

Institutional Affiliation

Ronald Reagan UCLA Medical Center



Neuro-Oncology, UCLA School of Medicine, 1998 - 1998


Surgery, UCLA School of Medicine, 1991 - 1992


Masters Business Administration, UCLA Anderson School of Management, 2016
PhD, UCLA, 1999
MD, Stanford University School of Medicine, 1991


Surgery/Neurosurgery, UCLA School of Medicine, 1992 - 1997

Board Certification

Neurological Surgery, American Board of Neurological Surgery, 2002

Contact Information


(310) 794-7788 - Patient appointments
(310) 825-5111 - Neurosurgery and Comprehensive Brain Tumor Program information and referral

Clinical Interests

Brain Tumor

Scientific Interests

Dr. Linda Liau's research efforts are focused on gene therapy and immunotherapy approaches in treating patients with malignant brain tumors.

Highlighted Publications

Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, Lai A, Cloughesy TF, Kornblum HI, Wu H, Fantin VR, Liau LM. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol. 2012 Mar;107(1):197-205. Epub 2011 Oct 21

Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM, Konkankit V. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res. 2011 Mar 15;17(6):1603-15. Epub 2010 Dec 6

Konkankit VV, Kim W, Koya RC, Eskin A, Dam MA, Nelson S, Ribas A, Liau LM, Prins RM. Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway. J Transl Med. 2011 Nov 7;9:192.

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2010 Jun 17;465(7300):966.

Prins RM, Cloughesy TF, Liau LM. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med. 2008 Jul 31;359(5):539-41.